No idea. There's a lot of potential. Personally been cleaned out for fractions of what things were worth in the past when management crumbled. Generally the first thing I suspect now.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%